Statement: The most common adverse events in the primary trial where Infection and Stomatitis.
Primary_evidence: Adverse Events 1:   Total: 14/81 (17.28%)   Neutropenia1/81 (1.23%)   Cataract1/81 (1.23%)   Ascites1/81 (1.23%)   Gastritis Hemorrhagic1/81 (1.23%)   Nausea1/81 (1.23%)   Stomatitis2/81 (2.47%)   Malaise1/81 (1.23%)   Oedema1/81 (1.23%)   Pain1/81 (1.23%)   Pyrexia1/81 (1.23%)   Infection2/81 (2.47%)   Upper Limb Fracture1/81 (1.23%)   Dehydration1/81 (1.23%)   Hypercalcemia1/81 (1.23%)